Danielsson Patrik, Ólafsdóttir Inga Sif, Benediktsdóttir Bryndis, Gíslason Thórarinn, Janson Christer
Department of Medical Sciences: Respiratory Medicine and Allergology, Uppsala University, Uppsala, Sweden.
Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.
To estimate chronic obstructive pulmonary disease (COPD) prevalence in Uppsala and the impact of risk factors on disease prevalence using the standardised methods of the Burden of Obstructive Lung Disease (BOLD) study initiative.
Randomly selected participants, aged 40 years or more (n = 548) responded to a questionnaire regarding smoking habits, respiratory symptoms, medical history, and exposure to airway irritants. Spirometry, with a post-bronchodilator test, was performed and COPD defined as post-bronchodilatory forced expiratory volume in 1 s (FEV(1))/forced vital capacity (FVC) < 0.70 or FEV(1)/FVC < lower limit of normality (LLN). Circulatory inflammatory markers were measured.
COPD prevalence was 16.2%, which was the fourth lowest prevalence of COPD, compared with 12 other BOLD centres. Main risk factors for COPD were increasing age [odds ratio (OR) = 2.08 per 10 years] and smoking (OR = 1.33 per 10 pack years). Higher education was protective (OR = 0.70 per 5 years). Previous tuberculosis was an almost significant risk factor for COPD (P = 0.08). Subjects with COPD reported more respiratory symptoms but only 29% had previous doctor diagnosed COPD, asthma, chronic bronchitis or emphysema. Participants with COPD had higher levels of C-reactive protein (P = 0.01), but no difference was observed in interleukin 6 (IL-6) levels. Using LLN instead of the fixed FEV(1) /FVC ratio reduced the prevalence of COPD to 10%.
COPD prevalence in Uppsala was similar to other BOLD centres in high-income countries. Apart from known COPD risk factors (age, smoking, lower educational level), a history of tuberculosis may be associated with COPD even in high-income countries. COPD remains under-diagnosed, as only 29% of subjects with COPD had a previously diagnosed lung disorder.
采用慢性阻塞性肺疾病负担(BOLD)研究计划的标准化方法,评估乌普萨拉慢性阻塞性肺疾病(COPD)的患病率以及危险因素对疾病患病率的影响。
随机选取40岁及以上的参与者(n = 548),他们回答了一份关于吸烟习惯、呼吸道症状、病史和气道刺激物暴露情况的问卷。进行了支气管扩张剂后肺量计测试,COPD定义为支气管扩张剂后1秒用力呼气量(FEV₁)/用力肺活量(FVC)< 0.70或FEV₁/FVC <正常下限(LLN)。测量了循环炎症标志物。
COPD患病率为16.2%,与其他12个BOLD中心相比,是COPD患病率第四低的地区。COPD的主要危险因素是年龄增长[每10年比值比(OR)= 2.08]和吸烟(每10包年OR = 1.33)。高等教育具有保护作用(每5年OR = 0.70)。既往肺结核几乎是COPD的一个危险因素(P = 0.08)。患有COPD的受试者报告了更多的呼吸道症状,但只有29%曾被医生诊断患有COPD、哮喘、慢性支气管炎或肺气肿。患有COPD的参与者C反应蛋白水平较高(P = 0.01),但白细胞介素6(IL - 6)水平未观察到差异。使用LLN而非固定的FEV₁/FVC比值,COPD患病率降至10%。
乌普萨拉的COPD患病率与高收入国家的其他BOLD中心相似。除了已知的COPD危险因素(年龄、吸烟、教育水平较低)外,即使在高收入国家,肺结核病史也可能与COPD有关。COPD仍未得到充分诊断,因为只有29%患有COPD的受试者曾被诊断患有肺部疾病。